List your company on Longevity Club — free.

Put your products in front of thousands of active longevity customers.

Claim free listing

Targovax Company

Targovax develops active immunotherapy in the form of cancer vaccines for application in post-operation treatments.

Last Funding Date: 2022-01-12
Headquarters: Oslo, Oslo, Norway
Funding Status: IPO
Estimated Revenue: $1M to $10M
Total Funding: 30331820
Investors Number: 5
Industry: Peptides and Proteins
Last Funding Type: Grant
Founded Date: 2010-01-01